osteoarthritis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: age 40 years or older; female, due to the higher prevalence of the disease; and clinical diagnosis of knee osteoarthritis according to the American College of Rheumatology (ACR) classification.
Exclusion criteria
Exclusion criteria: those who had: contraindications to the use of therapeutic ultrasound such as, area with hypoesthesia, area with vascular insufficiency, affections located in the tissue, diabetes mellitus, open wounds; hypersensitivity and allergy to Arnica or Diclofenac and its components; rheumatologic conditions such as rheumatoid arthritis; severe knee OA and lower limb thrombosis; who performed injections in the knee joint in the last 6 (six) months; balance disorders, neuropathy or sensory disturbances and skin lesions around the knee; who had undergone previous surgery on the knee joint or suffered a fractured knee joint.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Significant decrease in pain and stiffness scores and descriptive decrease in physical function score of patients with Knee Osteoarthritis determined through the WOMAC questionnaire applied before the first intervention and after the twelfth intervention, using the mann Whitney's teo test u for samples independents and the paired t-test and the wilcoxon test for dependent samples, considering a higher significance level of 5%. Decrease in pain in patients with osteoarthritis of the knee determined through the analogue pain scale (VAS) applied before and after each intervention, using the paired t test, considering a significance level greater than 5%. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are not expected | — |
Countries
Brazil